Jessica Jane Bartlett, CNM in Lehi, UT - Midwife

Jessica Jane Bartlett, CNM is a Midwife based in Lehi, Utah. Jessica Jane Bartlett is licensed to practice in Utah (license number 7949291-4402) and her current practice location is 177 N 500 E, Lehi, Utah. She can be reached at her office (for appointments etc.) via phone at (801) 368-8504.

NPI number for Jessica Jane Bartlett is 1548612013 and her current mailing address is 177 N 500 E, Lehi, Utah. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1548612013.

Contact Information

	Jessica Jane Bartlett, CNM
	177 N 500 E, Lehi, UT 84043-1941
	(801) 368-8504
	Not Available

Provider's Profile

Full Name	Jessica Jane Bartlett
Gender	Female
Speciality	Midwife
Location	177 N 500 E, Lehi, Utah
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1548612013
Provider Enumeration Date: 07/08/2016
Last Update Date: 02/14/2018

Medical Identifiers

Medical identifiers for Jessica Jane Bartlett such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1548612013	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
367A00000X	Advanced Practice Midwife	2016021962 (Missouri)	Secondary
176B00000X	Midwife	7949291-4402 (Utah)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jessica Jane Bartlett is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jessica Jane Bartlett, CNM 177 N 500 E, Lehi, UT 84043-1941 Ph: (801) 368-8504	Jessica Jane Bartlett, CNM 177 N 500 E, Lehi, UT 84043-1941 Ph: (801) 368-8504

News Archive

Researchers identify possible way to prevent headaches of climbers

By monitoring blood flow in the brains of six climbers scaling Mount Kilimanjaro in Tanzania, German medical researchers have identified a possible way to prevent the headaches that are a common feature of altitude sickness. This work appears in the latest issue of JNIRS—Journal of Near Infrared Spectroscopy.

The American College of Radiology selects Geraldine McGinty for Thorwarth Award

The American College of Radiology selected Geraldine McGinty, MD, MBA, FACR, as the 2018 recipient of the William T. Thorwarth, Jr., MD, Award.

Gene therapy could be potential treatment for neuropathic pain in cancer patients

A study providing new information about neuropathic pain afflicting some 90 percent of cancer patients who have had nerve damage caused by tumors, surgery, chemotherapy or radiation indicates gene therapy as a possible treatment.

Gilead submits NDA to FDA for fixed-dose combination of ledipasvir and sofosbuvir for hepatitis C infection

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for a once-daily fixed-dose combination of the NS5A inhibitor ledipasvir (LDV) 90 mg and the nucleotide analog polymerase inhibitor sofosbuvir (SOF) 400 mg for the treatment of chronic hepatitis C genotype 1 infection in adults.

Ockham to partner with Leukemia and Lymphoma Society to increase commitment to cancer philanthropy

Ockham Development will partner with the Leukemia and Lymphoma Society of North Carolina chapter during 2014 to increase its commitment to cancer-directed philanthropy and collaborate with the Society to support the company's personal health and fitness goals.

Jessica Jane Bartlett, CNM - Midwife in Lehi, UT